A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
BeOne Medicines
BeOne Medicines
Beijing Biotech
Beijing Biotech
Sellas Life Sciences Group
Amgen
Hoffmann-La Roche
Allogene Therapeutics
Lyell Immunopharma, Inc.
ModernaTX, Inc.
AstraZeneca
A2 Biotherapeutics Inc.
Celgene
Immatics US, Inc.
Regeneron Pharmaceuticals
AstraZeneca
ModernaTX, Inc.
Incyte Corporation
Haihe Biopharma Co., Ltd.
Amgen
DualityBio Inc.
GlaxoSmithKline
Blueprint Medicines Corporation
Hoffmann-La Roche
Kura Oncology, Inc.
Karyopharm Therapeutics Inc
Genmab
MediLink Therapeutics (Suzhou) Co., Ltd.
Seqker Biosciences, Inc.
Novelwise Pharmaceutical Corporation
Regeneron Pharmaceuticals
Immatics Biotechnologies GmbH
Incyte Corporation
Pfizer
Servier
Karyopharm Therapeutics Inc
Gilead Sciences
Arsenal Biosciences, Inc.
Advesya SAS
Regeneron Pharmaceuticals
BlueSphere Bio, Inc
Biotroy Therapeutics
Cellectis S.A.
Autolus Limited
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Aptose Biosciences Inc.
Curis, Inc.
Zhejiang ACEA Pharmaceutical Co. Ltd.
AbbVie
Genfleet Therapeutics (Shanghai) Inc.
Hoffmann-La Roche